Associate Professor Janice Fullerton

Tabs

Main

University role:

Senior Research Scientist

Phone:

02 9399 1836

Email:

j.fullerton@unsw.edu.au

Dr Jan Fullerton is a Senior Research Scientist at NeuRA and a Conjoint Associate Professor at UNSW.

She completed her PhD in human genetics at The University of Melbourne in 2001. Dr Fullerton completed five years postdoctoral training at The Wellcome Trust Centre for Human Genetics, University of Oxford (UK), where she developed her career interest in psychiatric genetics and complex trait analysis. Here she studied the genetic contributors to personality, depression and anxiety in both humans and mice.

Dr Fullerton returned to Australia in 2006 on a NHMRC Howard Florey Fellowship, which allowed her to join NeuRA to study the genetics of major mental illnesses, with a particular focus on bipolar disorder. In 2013, Dr Fullerton was promoted to Group Leader at NeuRA, where she heads a number of projects in gene discovery using the latest genomics technologies, as well as projects examining the role of specific genes in risk of major psychiatric conditions.

Qualifications:

Doctor of Philosophy (Medicine): The University of Melbourne: Australia

Honours Degree (First Class): The University of Melbourne: Australia

Bachelor of Science: The University of Melbourne: Australia

Grants:

In the last 5 years FTE (2014-2020) I have secured $6.55m in research funding/awards as a CI, of which $2.3m was category 1 and $4.5m was as CIA.

2019-2020 UNSW Mindgardens Neuroscience Network Alliance “Bipolar 45 and Up Study: clinical course and long-term health outcomes of people with BD using electronic health record data” Budget: $300,000

2019 NSW Health Biospecimen Collection Grant. 45 and Up Bipolar Study (EOI submitted 31 August 2018, invited for full application which was submitted 9 Dec 2018). Budget: $100,000

2017 NSW Health Office of Health and Medical Research - Sydney Collaborative Genomics “Genetic contributors, clinical course and pharmacogenomics of Bipolar Disorder using data linkage in NSW” CIs: Fullerton, Mitchell, Schofield, Havard, Toma, Maryanne O’Donnell. AIs: Green. ($2,460,000)

2017 NAB Foundation “Stronger Minds” grant “Identification of mutant genes that contribute to bipolar disorder” CIs: A Cooper, JM Fullerton ($100,000)

2016 MLC Community Foundation "Whole Genome Sequencing of families with mental illness: 9 nuclear families with bipolar disorder". CI: A Cooper, Collaborator: JM Fullerton ($70,000)

2014-2017 NHMRC project grant APP1063960 “Unravelling the genetic causes of bipolar disorder: lessons from rare but highly penetrant variants in very heritable forms of illness” CIA: JM Fullerton, CIB: PR Schofield ($684,890)

2014-2017 NHMRC project grant APP1066177 “The biology of risk for bipolar disorder: genetic effects in a high-risk longitudinal study” CIA: JM Fullerton, CIB: R Lenroot, CIC: JI Nurnberger Jr ($833,835)

Awards:

2014 Dean’s Rising Star Award, UNSW: “Significant contribution to research”.

2013 UNSW Silver star award CIA: J Fullerton, CIB: PR Schofield

2012 UNSW Gold star award CIA: J Fullerton, CIB: PR Schofield, CIC: JA Donald, CID: PB Mitchell

2010 UNSW Gold star award CIA: J Fullerton, CIB: PR Schofield, CIC: JA Donald, CID: PB Mitchell

2007 - 2008 NARSAD Young Investigator Award awarded by the National Alliance for Research on Schizophrenia and Depression, New York, USA (US$60,000). CI: J Fullerton, Sponsor: PR Schofield

2007 Brain Sciences UNSW 2007 Symposium Post-doctoral “Best Poster Award” awarded to J Fullerton

2005 – 2007 Howard Florey Centenary Research Fellowship awarded by the National Health and Medical Research Council, Australia. Grant #: 325643. CI: J Fullerton, Sponsor: PR Schofield

Keywords:

bipolar disorder

genomics

psychiatry

prodromal phase

epigenomics

genome-wide association

pharmacogenomics

electronic health records

neuroimaging

cognition

next generation sequencing

Research

Research activities:

My group is interested in identifying and characterising genes which increase risk to mental illness, particularly bipolar disorder and schizophrenia. While these are clinically distinct disorders, bipolar disorder and schizophrenia share a common genetic foundation, as well as overlapping constellations of symptoms. Understanding the genetic contributors to mental illness enable us to improve our understanding of the biological basis of these psychiatric conditions, identify similarities and differences across disorders, and ultimately improve treatment of psychiatric disorders through these discoveries. Identifying the specific genes which are impaired in mental illness also helps to demystify the functioning of the human brain, and to comprehend the orchestration of events which leads to development of a healthy or unhealthy brain.

Genetic and epigenetic contributors to bipolar disorder in a high risk cohort

The offspring of individuals with bipolar disorder are at increased risk of mental illness, but our tools to predict which of these genetically at-risk young people will eventually develop disorder are very imprecise. Longitudinal studies that ascertain at-risk participants and monitor them prospectively are an effective approach for identifying early clinical and biological markers of future illness. This study examines genomic risk load of genetic and epigenetic factors, early structural brain changes and clinical information to determine if we can use biological signatures to predict which individuals will ultimately transition to illness, and identify targets for intervention prior to onset of symptoms which lead to a clinical diagnosis.

Genetic contributors, clinical course and pharmacogenomics of Bipolar Disorder in a large population cohort

Bipolar Disorder is a severe and debilitating psychiatric condition, for which the clinical course is highly variable between individuals, and the specific genetic causes remain largely obscure. This landmark study aims to use linked administrative health record data and state-of-the-art genomics technologies to address four key knowledge gaps: 1) identification of genes and molecular pathways which increase risk of illness; 2) pharmacogenomics studies to identify genetic signatures which may predict responsiveness to commonly used medicinal treatments; 3) examination of the impact of rare disruptive genetic variants on disease severity; and 4) consideration of the genetic correlates of both the course and severity of illness, and relationships to general medical conditions which more commonly present in people with bipolar disorder (such as cardiovascular disease, type II diabetes and asthma) and which further reduce quality of life and significantly impact overall health of people living with this condition.

Investigation of rare variants which increase risk to bipolar disorder in families with a high density of illness

Advances in technology have enabled sequencing at the level of the entire genome to become a reality. We have access to number of rare families with highly heritable forms of bipolar disorder, for which we will apply this powerful technology to identify specific genetic factors which increase disease risk. We assess loss-of-function variation within genes, at both the level of single base mutations and variation in gene copy number, which track with illness in these families to identify new genes which contribute to illness.

International collaborative consortia involvement

We are active contributors to a number of large international collaborative studies, including the Psychiatric Genomics Consortium (PGC), the Bipolar Sequencing Consortium (BSC), the Bipolar High Risk Consortium, and have contributed to a number of projects through the Enhancing Neuroimaging Genetics through Meta-Analysis (ENIGMA) consortia. These efforts aim to identify risk genes which contribute to disease, and examine their effect on brain structure, function and disease.

Field of Research (FOR) Tag:

Neurogenetics

Genomics

Pharmacogenomics

Psychiatry

Socio-economic Objective (SEO) tags:

Mental Health

Public Health (excl. Specific Population Health) not elsewhere classified

Teaching & Supervision

I am available to supervise:

Yes

Areas of supervision:

ILP, Honours, Masters, PhD.

Currently supervising:

Sonia Hesam Shariati

Javad Jamshidi

Oliver Watkeys

Hayley North

Jessica Chandra

Supervision keywords:

bipolar disorder

epigenomics

genetics

genomics

electronic health records

next generation sequencing

pharmacogenomics

mental health

resilience

high risk

longitudinal studies

psychiatry

genome-wide association

prodromal phase

neuroimaging

cognitive ability

Teaching:

Seeking ILP students and clinicians for short-term research training project on the "Genetic contributors, clinical course and pharmacogenomics of Bipolar Disorder in a large population cohort" project, supported by the Mindgardens Neuroscience Network initiative.

Publications related to this Person

Journal articles

Lee PH; Anttila V; Won H; Feng YCA; Rosenthal J; Zhu Z; Tucker-Drob EM; Nivard MG; Grotzinger AD; Posthuma D, 2019, 'Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders', Cell, vol. 179, pp. 1469 - 1482.e11, http://dx.doi.org/10.1016/j.cell.2019.11.020

Andlauer TFM; Guzman-Parra J; Streit F; Strohmaier J; González MJ; Gil Flores S; Cabaleiro Fabeiro FJ; del Río Noriega F; Perez FP; Haro González J, 2019, 'Bipolar multiplex families have an increased burden of common risk variants for psychiatric disorders', Molecular Psychiatry, http://dx.doi.org/10.1038/s41380-019-0558-2

Toma C; Díaz-Gay M; Soares de Lima Y; Arnau-Collell C; Franch-Expósito S; Muñoz J; Overs B; Bonjoch L; Carballal S; Ocaña T, 2019, 'Identification of a Novel Candidate Gene for Serrated Polyposis Syndrome Germline Predisposition by Performing Linkage Analysis Combined With Whole-Exome Sequencing', Clinical and translational gastroenterology, vol. 10, pp. e00100, http://dx.doi.org/10.14309/ctg.0000000000000100

Torrico B; Shaw AD; Mosca R; Vivó-Luque N; Hervás A; Fernàndez-Castillo N; Aloy P; Bayés M; Fullerton JM; Cormand B, 2019, 'Truncating variant burden in high-functioning autism and pleiotropic effects of LRP1 across psychiatric phenotypes', Journal of Psychiatry and Neuroscience, vol. 44, pp. 350 - 359, http://dx.doi.org/10.1503/jpn.180184

de Zwarte SMC; Brouwer RM; Agartz I; Alda M; Aleman A; Alpert KI; Bearden CE; Bertolino A; Bois C; Bonvino A, 2019, 'The Association Between Familial Risk and Brain Abnormalities Is Disease Specific: An ENIGMA-Relatives Study of Schizophrenia and Bipolar Disorder', Biological Psychiatry, vol. 86, pp. 545 - 556, http://dx.doi.org/10.1016/j.biopsych.2019.03.985

Fullerton JM; Nurnberger JI, 2019, 'Polygenic risk scores in psychiatry: Will they be useful for clinicians? [version 1; peer review: 4 approved]', F1000Research, vol. 8, http://dx.doi.org/10.12688/f1000research.18491.1

Fullerton JM; Nurnberger JI, 2019, 'Polygenic risk scores in psychiatry: Will they be useful for clinicians?', F1000Research, vol. 8, http://dx.doi.org/10.12688/f1000research.18491.1

Stapp EK; Musci RJ; Fullerton JM; Glowinski AL; McInnis M; Mitchell PB; Hulvershorn LA; Ghaziuddin N; Roberts GMP; Merikangas KR, 2019, 'Patterns and predictors of family environment among adolescents at high and low risk for familial bipolar disorder', Journal of Psychiatric Research, vol. 114, pp. 153 - 160, http://dx.doi.org/10.1016/j.jpsychires.2019.05.003

Torrico B; Shaw AD; Mosca R; Vivó-Luque N; Hervás A; Fernàndez-Castillo N; Aloy P; Bayés M; Fullerton JM; Cormand B, 2019, 'Truncating variant burden in high-functioning autism and pleiotropic effects of LRP1 across psychiatric phenotypes', J Psychiatry Neurosci, vol. 44, pp. 350 - 359, http://dx.doi.org/10.1503/jpn.180184

Stahl EA; Breen G; Forstner AJ; McQuillin A; Ripke S; Trubetskoy V; Mattheisen M; Wang Y; Coleman JRI; Gaspar HA, 2019, 'Genome-wide association study identifies 30 loci associated with bipolar disorder', Nature Genetics, vol. 51, pp. 793 - 803, http://dx.doi.org/10.1038/s41588-019-0397-8

Watkeys O; Cohen-Woods S; Quidé Y; Cairns M; Overs B; Fullerton J; Green M, 2019, 'Derivation of Poly-Methylomic Profile Scores for Schizophrenia', , http://dx.doi.org/10.1101/607309

van Erp TGM; Walton E; Hibar DP; Schmaal L; Jiang W; Glahn DC; Pearlson GD; Yao N; Fukunaga M; Hashimoto R, 2019, 'Reply to: New Meta- and Mega-analyses of Magnetic Resonance Imaging Findings in Schizophrenia: Do They Really Increase Our Knowledge About the Nature of the Disease Process?', Biological Psychiatry, vol. 85, pp. e35 - e39, http://dx.doi.org/10.1016/j.biopsych.2018.10.003

Kalman JL; Papiol S; Forstner AJ; Heilbronner U; Degenhardt F; Strohmaier J; Adli M; Adorjan K; Akula N; Alda M, 2019, 'Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study', Bipolar Disorders, vol. 21, pp. 68 - 75, http://dx.doi.org/10.1111/bdi.12659

Ghaziuddin N; Shamseddeen W; Bertram H; McInnis M; Wilcox HC; Mitchell PB; Fullerton JM; Roberts GMP; Glowinski AL; Kamali M, 2019, 'Salivary melatonin onset in youth at familial risk for bipolar disorder', Psychiatry Research, vol. 274, pp. 49 - 57, http://dx.doi.org/10.1016/j.psychres.2019.02.013

de Jong S; Diniz MJA; Saloma A; Gadelha A; Santoro ML; Ota VK; Noto C; Wray NR; Ripke S; Mattheisen M, 2018, 'Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder', Communications Biology, vol. 1, http://dx.doi.org/10.1038/s42003-018-0155-y

Toma C; Pierce KD; Shaw AD; Heath A; Mitchell PB; Schofield PR; Fullerton JM, 2018, 'Comprehensive cross-disorder analyses of CNTNAP2 suggest it is unlikely to be a primary risk gene for psychiatric disorders', PLoS Genetics, vol. 14, http://dx.doi.org/10.1371/journal.pgen.1007535

Watkeys OJ; Kremerskothen K; Quidé Y; Fullerton JM; Green MJ, 2018, 'Glucocorticoid receptor gene (NR3C1) DNA methylation in association with trauma, psychopathology, transcript expression, or genotypic variation: A systematic review', Neuroscience and Biobehavioral Reviews, vol. 95, pp. 85 - 122, http://dx.doi.org/10.1016/j.neubiorev.2018.08.017

Nunes A; Schnack HG; Ching CRK; Agartz I; Akudjedu TN; Alda M; Alnæs D; Alonso-Lana S; Bauer J; Baune BT, 2018, 'Using structural MRI to identify bipolar disorders – 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working Group', Molecular Psychiatry, http://dx.doi.org/10.1038/s41380-018-0228-9

van Erp TGM; Walton E; Hibar DP; Schmaal L; Jiang W; Glahn DC; Pearlson GD; Yao N; Fukunaga M; Hashimoto R, 2018, 'Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium', Biological Psychiatry, vol. 84, pp. 644 - 654, http://dx.doi.org/10.1016/j.biopsych.2018.04.023

Anttila V; Bulik-Sullivan B; Finucane HK; Walters RK; Bras J; Duncan L; Escott-Price V; Falcone GJ; Gormley P; Malik R, 2018, 'Analysis of shared heritability in common disorders of the brain', Science, vol. 360, http://dx.doi.org/10.1126/science.aap8757

Kong XZ; Mathias SR; Guadalupe T; Abé C; Agartz I; Akudjedu TN; Aleman A; Alhusaini S; Allen NB; Ames D, 2018, 'Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA consortium', Proceedings of the National Academy of Sciences of the United States of America, vol. 115, pp. E5154 - E5163, http://dx.doi.org/10.1073/pnas.1718418115

Ruderfer DM; Ripke S; McQuillin A; Boocock J; Stahl EA; Pavlides JMW; Mullins N; Charney AW; Ori APS; Loohuis LMO, 2018, 'Genomic Dissection of Bipolar Disorder and Schizophrenia, Including 28 Subphenotypes', Cell, vol. 173, pp. 1705 - 1715.e16, http://dx.doi.org/10.1016/j.cell.2018.05.046

Tsai S-Y; Catts VS; Fullerton JM; Corley SM; Fillman SG; Weickert CS, 2018, 'Nuclear Receptors and Neuroinflammation in Schizophrenia.', Mol Neuropsychiatry, vol. 3, pp. 181 - 191, http://dx.doi.org/10.1159/000485565

Reinbold CS; Forstner AJ; Hecker J; Fullerton JM; Hoffmann P; Hou L; Heilbronner U; Degenhardt F; Adli M; Akiyama K, 2018, 'Analysis of the influence of microRNAs in lithium response in bipolar disorder', Frontiers in Psychiatry, vol. 9, http://dx.doi.org/10.3389/fpsyt.2018.00207

Toma C; Shaw AD; Allcock RJN; Heath A; Pierce KD; Mitchell PB; Schofield PR; Fullerton JM, 2018, 'An examination of multiple classes of rare variants in extended families with bipolar disorder', Translational Psychiatry, vol. 8, http://dx.doi.org/10.1038/s41398-018-0113-y

Hibar DP; Westlye LT; Doan NT; Jahanshad N; Cheung JW; Ching CRK; Versace A; Bilderbeck AC; Uhlmann A; Mwangi B, 2018, 'Cortical abnormalities in bipolar disorder: An MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group', Molecular Psychiatry, vol. 23, pp. 932 - 942, http://dx.doi.org/10.1038/mp.2017.73

Fullerton JM; Klauser P; Lenroot RK; Shaw AD; Overs B; Heath A; Cairns MJ; Atkins J; Scott R; Schofield PR, 2018, 'Differential effect of disease-associated ST8SIA2 haplotype on cerebral white matter diffusion properties in schizophrenia and healthy controls', Translational Psychiatry, vol. 8, http://dx.doi.org/10.1038/s41398-017-0052-z

Amare AT; Schubert KO; Hou L; Clark SR; Papiol S; Heilbronner U; Degenhardt F; Tekola-Ayele F; Hsu YH; Shekhtman T, 2018, 'Association of polygenic score for schizophrenia and HLA antigen and inflammation genes with response to lithium in bipolar affective disorder: A genome-wide association study', JAMA Psychiatry, vol. 75, pp. 65 - 74, http://dx.doi.org/10.1001/jamapsychiatry.2017.3433

Mühleisen TW; Reinbold CS; Forstner AJ; Abramova LI; Alda M; Babadjanova G; Bauer M; Brennan P; Chuchalin A; Cruceanu C, 2018, 'Gene set enrichment analysis and expression pattern exploration implicate an involvement of neurodevelopmental processes in bipolar disorder', Journal of Affective Disorders, vol. 228, pp. 20 - 25, http://dx.doi.org/10.1016/j.jad.2017.11.068

Chang H; Hoshina N; Zhang C; Ma Y; Cao H; Wang Y; Wu DD; Bergen SE; Landén M; Hultman CM, 2018, 'The protocadherin 17 gene affects cognition, personality, amygdala structure and function, synapse development and risk of major mood disorders', Molecular Psychiatry, vol. 23, pp. 400 - 412, http://dx.doi.org/10.1038/mp.2016.231

Corry J; Green M; Roberts G; Fullerton JM; Schofield PR; Mitchell PB, 2017, 'Does perfectionism in bipolar disorder pedigrees mediate associations between anxiety/stress and mood symptoms?', International Journal of Bipolar Disorders, vol. 5, http://dx.doi.org/10.1186/s40345-017-0102-8

Witt SH; Streit F; Jungkunz M; Frank J; Awasthi S; Reinbold CS; Treutlein J; Degenhardt F; Forstner AJ; Heilmann-Heimbach S, 2017, 'Genome-wide association study of borderline personality disorder reveals genetic overlap with bipolar disorder, major depression and schizophrenia', Translational psychiatry, vol. 7, pp. e1155, http://dx.doi.org/10.1038/tp.2017.115

van Hulzen KJE; Scholz CJ; Franke B; Ripke S; Klein M; McQuillin A; Sonuga-Barke EJS; Kelsoe JR; Landén M; Andreassen OA, 2017, 'Genetic Overlap Between Attention-Deficit/Hyperactivity Disorder and Bipolar Disorder: Evidence From Genome-wide Association Study Meta-analysis', Biological Psychiatry, vol. 82, pp. 634 - 641, http://dx.doi.org/10.1016/j.biopsych.2016.08.040

Wilcox HC; Fullerton JM; Glowinski AL; Benke K; Kamali M; Hulvershorn LA; Stapp EK; Edenberg HJ; Roberts GMP; Ghaziuddin N, 2017, 'Traumatic Stress Interacts With Bipolar Disorder Genetic Risk to Increase Risk for Suicide Attempts', Journal of the American Academy of Child and Adolescent Psychiatry, vol. 56, pp. 1073 - 1080, http://dx.doi.org/10.1016/j.jaac.2017.09.428

Hulvershorn LA; King J; Monahan PO; Wilcox HC; Mitchell PB; Fullerton JM; Edenberg HJ; Roberts GMP; Kamali M; Glowinski AL, 2017, 'Substance use disorders in adolescent and young adult relatives of probands with bipolar disorder: What drives the increased risk?', Comprehensive Psychiatry, vol. 78, pp. 130 - 139, http://dx.doi.org/10.1016/j.comppsych.2017.07.010

Klauser P; Baker ST; Cropley VL; Bousman C; Fornito A; Cocchi L; Fullerton JM; Rasser P; Schall U; Henskens F, 2017, 'White Matter Disruptions in Schizophrenia Are Spatially Widespread and Topologically Converge on Brain Network Hubs', Schizophrenia bulletin, vol. 43, pp. 425 - 435, http://dx.doi.org/10.1093/schbul/sbw100

Forstner AJ; Hecker J; Hofmann A; Maaser A; Reinbold CS; Mühleisen TW; Leber M; Strohmaier J; Degenhardt F; Treutlein J, 2017, 'Identification of shared risk loci and pathways for bipolar disorder and schizophrenia', PLoS ONE, vol. 12, http://dx.doi.org/10.1371/journal.pone.0171595

Chang H; Li L; Peng T; Grigoroiu-Serbanescu M; Bergen SE; Landén M; Hultman CM; Forstner AJ; Strohmaier J; Hecker J, 2017, 'Identification of a Bipolar Disorder Vulnerable Gene CHDH at 3p21.1', Molecular Neurobiology, vol. 54, pp. 5166 - 5176, http://dx.doi.org/10.1007/s12035-016-0041-x

Hou L; Bergen SE; Akula N; Song J; Hultman CM; Landén M; Adli M; Alda M; Ardau R; Arias B, 2016, 'Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder', Human Molecular Genetics, vol. 25, pp. 3383 - 3394, http://dx.doi.org/10.1093/hmg/ddw181

Hou L; Heilbronner U; Degenhardt F; Adli M; Akiyama K; Akula N; Ardau R; Arias B; Backlund L; Banzato CEM, 2016, 'Genetic variants associated with response to lithium treatment in bipolar disorder: A genome-wide association study', The Lancet, vol. 387, pp. 1085 - 1093, http://dx.doi.org/10.1016/S0140-6736(16)00143-4

Li M; Luo XJ; Landén M; Bergen SE; Hultman CM; Li X; Zhang W; Yao YG; Zhang C; Liu J, 2016, 'Impact of a cis-associated gene expression SNP on chromosome 20q11.22 on bipolar disorder susceptibility, hippocampal structure and cognitive performance', British Journal of Psychiatry, vol. 208, pp. 128 - 137, http://dx.doi.org/10.1192/bjp.bp.114.156976

Forstner AJ; Hofmann A; Maaser A; Sumer S; Khudayberdiev S; Mühleisen TW; Leber M; Schulze TG; Strohmaier J; Degenhardt F, 2015, 'Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder', Translational Psychiatry, vol. 5, http://dx.doi.org/10.1038/tp.2015.159

Fullerton JM; Koller DL; Edenberg HJ; Foroud T; Liu H; Glowinski AL; Mcinnis MG; Wilcox HC; Frankland A; Roberts G, 2015, 'Assessment of first and second degree relatives of individuals with bipolar disorder shows increased genetic risk scores in both affected relatives and young At-Risk Individuals', American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, vol. 168, pp. 617 - 629, http://dx.doi.org/10.1002/ajmg.b.32344

Kamien B; Harraway J; Lundie B; Smallhorne L; Gibbs V; Heath A; Fullerton JM, 2015, 'Characterization of a 520kb deletion on chromosome 15q26.1 including ST8SIA2 in a patient with behavioral disturbance, autism spectrum disorder, and epilepsy: Additional information', American Journal of Medical Genetics, Part A, vol. 167, pp. 1424 - 1424, http://dx.doi.org/10.1002/ajmg.a.36846

Li M; Luo XJ; Rietschel M; Lewis CM; Mattheisen M; Müller-Myhsok B; Jamain S; Leboyer M; Landén M; Thompson PM, 2014, 'Allelic differences between Europeans and Chinese for CREB1 SNPs and their implications in gene expression regulation, hippocampal structure and function, and bipolar disorder susceptibility', Molecular Psychiatry, vol. 19, pp. 452 - 461, http://dx.doi.org/10.1038/mp.2013.37

Nurnberger JI; Koller DL; Jung J; Edenberg HJ; Foroud T; Guella I; Vawter MP; Kelsoe JR; Sklar P; Ripke S, 2014, 'Identification of pathways for bipolar disorder: A meta-analysis', JAMA Psychiatry, vol. 71, pp. 657 - 664, http://dx.doi.org/10.1001/jamapsychiatry.2014.176

Yuan Q; Rubic M; Seah J; Rae C; Wright IMR; Kaltenbach K; Feller JM; Abdel-Latif ME; Chu C; Oei JL, 2014, 'Do maternal opioids reduce neonatal regional brain volumes: A pilot study', Journal of Perinatology, vol. 34, pp. 909 - 913, http://dx.doi.org/10.1038/jp.2014.111

Shaw AD; Tiwari Y; Kaplan W; Heath A; Mitchell PB; Schofield PR; Fullerton JM, 2014, 'Characterisation of genetic variation in ST8SIA2 and its interaction region in NCAM1 in patients with bipolar disorder', PLoS ONE, vol. 9, http://dx.doi.org/10.1371/journal.pone.0092556

Joshi D; Fullerton JM; Weickert CS, 2014, 'Elevated ErbB4 mRNA is related to interneuron deficit in prefrontal cortex in schizophrenia', Journal of Psychiatric Research, vol. 53, pp. 125 - 132, http://dx.doi.org/10.1016/j.jpsychires.2014.02.014

Mühleisen TW; Leber M; Schulze TG; Strohmaier J; Degenhardt F; Treutlein J; Mattheisen M; Forstner AJ; Schumacher J; Breuer R, 2014, 'Genome-wide association study reveals two new risk loci for bipolar disorder', Nature Communications, vol. 5, http://dx.doi.org/10.1038/ncomms4339

Steinberg S; Huttenlocher J; Thorsteinsdottir U; Kong A; Collier DA; Stefansson H; Stefansson K; De Jong S; Ophoff RA; Mattheisen M, 2014, 'Common variant at 16p11.2 conferring risk of psychosis', Molecular Psychiatry, vol. 19, pp. 108 - 114, http://dx.doi.org/10.1038/mp.2012.157

Kamien B; Harraway J; Lundie B; Smallhorne L; Gibbs V; Heath A; Fullerton JM, 2013, 'Characterization of a 520kb deletion on chromosome 15q26.1 including ST8SIA2 in a patient with behavioral disturbance, autism spectrum disorder, and epilepsy', American Journal of Medical Genetics, Part A, http://dx.doi.org/10.1002/ajmg.a.36345

Dobson-Stone C; Luty AA; Thompson EM; Blumbergs P; Brooks WS; Short CL; Field CD; Panegyres PK; Hecker J; Solski JA, 2013, 'Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: Genetic, clinical and neuropathological analysis', Acta Neuropathologica, vol. 125, pp. 523 - 533, http://dx.doi.org/10.1007/s00401-013-1078-9

Manchia M; Adli M; Akula N; Ardau R; Aubry JM; Backlund L; Banzato CEM; Baune BT; Bellivier F; Bengesser S, 2013, 'Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report', PLoS ONE, vol. 8, http://dx.doi.org/10.1371/journal.pone.0065636

Hsu SC; Sears RL; Lemos RR; Quintáns B; Huang A; Spiteri E; Nevarez L; Mamah C; Zatz M; Pierce KD, 2013, 'Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification', Neurogenetics, vol. 14, pp. 11 - 22, http://dx.doi.org/10.1007/s10048-012-0349-2

Sinclair D; Fullerton JM; Webster MJ; Weickert CS, 2012, 'Glucocorticoid receptor 1B and 1C mRNA transcript alterations in schizophrenia and bipolar disorder, and their possible regulation by GR gene variants', PLoS ONE, vol. 7, http://dx.doi.org/10.1371/journal.pone.0031720

Weickert CS; Tiwari Y; Schofield PR; Mowry BJ; Fullerton JM, 2012, 'Schizophrenia-associated HapICE haplotype is associated with increased NRG1 type III expression and high nucleotide diversity', Translational Psychiatry, vol. 2, http://dx.doi.org/10.1038/tp.2012.25

Sinclair D; Webster MJ; Fullerton JM; Weickert CS, 2012, 'Glucocorticoid receptor mRNA and protein isoform alterations in the orbitofrontal cortex in schizophrenia and bipolar disorder', BMC Psychiatry, vol. 12, http://dx.doi.org/10.1186/1471-244X-12-84

Li M; Wang Y; Zheng XB; Ikeda M; Iwata N; Luo XJ; Chong SA; Lee J; Rietschel M; Zhang F, 2012, 'Meta-analysis and brain imaging data support the involvement of VRK2 (rs2312147) in schizophrenia susceptibility', Schizophrenia Research, vol. 142, pp. 200 - 205, http://dx.doi.org/10.1016/j.schres.2012.10.008

McAuley EZ; Scimone A; Tiwari Y; Agahi G; Mowry BJ; Holliday EG; Donald JA; Weickert CS; Mitchell PB; Schofield PR, 2012, 'Identification of sialyltransferase 8B as a generalized susceptibility gene for psychotic and mood disorders on chromosome 15q25-26', PLoS ONE, vol. 7, http://dx.doi.org/10.1371/journal.pone.0038172

Sklar P; Ripke S; Scott LJ; Andreassen OA; Cichon S; Craddock N; Edenberg HJ; Nurnberger JI; Rietschel M; Blackwood D, 2011, 'Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4', Nature Genetics, vol. 43, pp. 977 - 985, http://dx.doi.org/10.1038/ng.943

Fullerton JM; Tiwari Y; Agahi G; Heath A; Berk M; Mitchell PB; Schofield PR, 2010, 'Assessing oxidative pathway genes as risk factors for bipolar disorder', Bipolar Disorders, vol. 12, pp. 550 - 556, http://dx.doi.org/10.1111/j.1399-5618.2010.00834.x

Mitchell PB; Meiser B; Wilde A; Fullerton J; Donald J; Wilhelm K; Schofield PR, 2010, 'Predictive and diagnostic genetic testing in psychiatry', Psychiatric Clinics of North America, vol. 33, pp. 225 - 243, http://dx.doi.org/10.1016/j.psc.2009.10.001

Fullerton JM; Donald JA; Mitchell PB; Schofield PR, 2010, 'Two-Dimensional Genome Scan Identifies Multiple Genetic Interactions in Bipolar Affective Disorder', Biological Psychiatry, vol. 67, pp. 478 - 486, http://dx.doi.org/10.1016/j.biopsych.2009.10.022

McAuley EZ; Blair IP; Liu Z; Fullerton JM; Scimone A; Van Herten M; Evans MR; Kirkby KC; Donald JA; Mitchell PB, 2009, 'A genome screen of 35 bipolar affective disorder pedigrees provides significant evidence for a susceptibility locus on chromosome 15q25-26', Molecular Psychiatry, vol. 14, pp. 492 - 500, http://dx.doi.org/10.1038/sj.mp.4002146

McAuley EZ; Fullerton JM; Blair IP; Donald JA; Mitchell PB; Schofield PR, 2009, 'Association between the serotonin 2A receptor gene and bipolar affective disorder in an Australian cohort.', Psychiatric genetics, vol. 19, pp. 244 - 252

Fullerton JM; Willis-Owen SAG; Yalcin B; Shifman S; Copley RR; Miller SR; Bhomra A; Davidson S; Oliver PL; Mott R, 2008, 'Human-Mouse Quantitative Trait Locus Concordance and the Dissection of a Human Neuroticism Locus', Biological Psychiatry, vol. 63, pp. 874 - 883, http://dx.doi.org/10.1016/j.biopsych.2007.10.019

Mitchell PB; Fullerton J; Donald J; Schofield PR, 2008, 'Two-dimensional genome scan identifies complex epistatic interactions in bipolar disorder', BIPOLAR DISORDERS, vol. 10, pp. 15 - 15, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000252711100037&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fullerton JM; Liu Z; Badenhop RF; Scimone A; Blair IP; Van Herten M; Donald JA; Mitchell PB; Schofield PR, 2008, 'Genome screen of 15 Australian bipolar affective disorder pedigrees supports previously identified loci for bipolar susceptibility genes', Psychiatric Genetics, vol. 18, pp. 156 - 161, http://dx.doi.org/10.1097/YPG.0b013e3282fa1861

Fullerton J; Heath A; Mitchell P; Schofield P, 2006, 'Investigation of circadian disruption in bipolar disorder.', Acta Neuropsychiatr, vol. 18, pp. 251, http://dx.doi.org/10.1017/S0924270800030283

Schofield PR; Blair IP; Chetcuti A; McAuley EZ; Fullerton JM; Donald JA; Mitchell PB, 2006, '03-04 Genetic and genomic approaches to better understanding bipolar disorder.', Acta Neuropsychiatr, vol. 18, pp. 321, http://dx.doi.org/10.1017/S0924270800032038

Fullerton J, 2006, 'New approaches to the genetic analysis of neuroticism and anxiety', Behavior Genetics, vol. 36, pp. 147 - 161, http://dx.doi.org/10.1007/s10519-005-9000-4

Willis-Owen SAG; Fullerton J; Surtees PG; Wainwright NWJ; Miller S; Flint J, 2005, 'The Val66Met coding variant of the brain-derived neurotrophic factor (BDNF) gene does not contribute toward variation in the personality trait neuroticism', Biological Psychiatry, vol. 58, pp. 738 - 742, http://dx.doi.org/10.1016/j.biopsych.2005.05.014

Yalcin B; Fullerton J; Miller S; Keays DA; Brady S; Bhomra A; Jefferson A; Volpi E; Copley RR; Flint J, 2004, 'Unexpected complexity in the haplotypes of commonly used inbred strains of laboratory mice', Proceedings of the National Academy of Sciences of the United States of America, vol. 101, pp. 9734 - 9739, http://dx.doi.org/10.1073/pnas.0401189101

Khoo JP; Nicoli T; Alp NJ; Fullerton J; Flint J; Channon KM, 2004, 'Congenic mapping and genotyping of the tetrahydrobiopterin-deficient hph-1 mouse', Molecular Genetics and Metabolism, vol. 82, pp. 251 - 254, http://dx.doi.org/10.1016/j.ymgme.2004.04.006

Yalcin B; Willis-Owen SAG; Fullerton J; Meesaq A; Deacon RM; Rawlins JNP; Copley RR; Morris AP; Flint J; Mott R, 2004, 'Genetic dissection of a behavioral quantitative trait locus shows that Rgs2 modulates anxiety in mice', Nature Genetics, vol. 36, pp. 1197 - 1202, http://dx.doi.org/10.1038/ng1450

Talbot CJ; Radcliffe RA; Fullerton J; Hitzemann R; Wehner JM; Flint J, 2003, 'Fine scale mapping of a genetic locus for conditioned fear', Mammalian Genome, vol. 14, pp. 223 - 230, http://dx.doi.org/10.1007/s00335-002-3059-5

Fullerton J; Cubin M; Tiwari H; Wang C; Bomhra A; Davidson S; Miller S; Fairburn C; Goodwin G; Neale MC, 2003, 'Linkage analysis of extremely discordant and concordant sibling pairs identifies quantitative-trait loci that influence variation in the human personality trait neuroticism', American Journal of Human Genetics, vol. 72, pp. 879 - 890, http://dx.doi.org/10.1086/374178

Fullerton J; Paprocki P; Foote S; Mackey DA; Williamson R; Forrest S, 2002, 'Identity-by-descent approach to gene localisation in eight individuals affected by keratoconus from north-west Tasmania, Australia', Human Genetics, vol. 110, pp. 462 - 470, http://dx.doi.org/10.1007/s00439-002-0705-7

Forrest S; Dunn K; Elliott K; Fitzpatrick E; Fullerton J; McCarthy M; Brown J; Hill D; Williamson R, 1999, 'Identifying genes predisposing to atopic eczema', Journal of Allergy and Clinical Immunology, vol. 104, pp. 1066 - 1070, http://dx.doi.org/10.1016/S0091-6749(99)70090-4

Conference Papers

Fullerton J; lenroot R; roberts G; overs B; frankland A; schofield P; mitchell P, 2015, 'Neurodevelopmental Trajectories in Young People at High Familial Risk for Bipolar Disorder', in European Neuropsychopharmacology, XXIIIrd World Congress of Psychiatric Genetics, Toronto, presented at XXIIIrd World Congress of Psychiatric Genetics, Toronto, 28 - 31 October 2015, http://dx.doi.org/10.1016/j.euroneuro.2015.09.009

Mitchell P; Roberts G; Frankland A; Breakspear M; Schofield P; Fullerton J, 2014, 'Using brain imaging and genetics to identify those at high risk for bipolar disorder', in INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, CAMBRIDGE UNIV PRESS, Vancouver, CANADA, pp. 14 - 14, presented at 29th CINP World Congress of Neuropsychopharmacology, Vancouver, CANADA, 22 - 26 June 2014, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339769200054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Anderson-Schmidt H; Beltcheva O; Brandon MD; Byrne EM; Diehl EJ; Duncan L; Gonzalez SD; Hannon E; Kantojärvi K; Karagiannidis I, 2013, 'Selected rapporteur summaries from the XX World Congress of Psychiatric Genetics, Hamburg, Germany, October 14-18, 2012.', in Am J Med Genet B Neuropsychiatr Genet, United States, pp. 96 - 121, United States, http://dx.doi.org/10.1002/ajmg.b.32132

Mitchell P; Roberts G; Fullerton JM; Green M; Breakspear M; Frankland A; Levy F; Lenroot R; Wen W; Lau P, 2013, 'Imaging and genetic studies in youth at high risk for bipolar disorder', in BIPOLAR DISORDERS, WILEY-BLACKWELL, Miami Beach, FL, pp. 41 - 41, presented at 10th International Conference on Bipolar Disorder of the International-Society-for-Bipolar-Disorders, Miami Beach, FL, 13 - 16 June 2013, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000319826800087&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Weickert CS; Tiwari Y; Schofield PR; Fullerton JM, 2011, 'Linking the NRG1-realted Genetic Risk of Schizophrenia to Increased Type III NRG1 mRNA', in BIOLOGICAL PSYCHIATRY, ELSEVIER SCIENCE INC, San Francisco, CA, pp. 13S - 13S, presented at 66th Annual Meeting of the Society-of-Biological-Psychiatry, San Francisco, CA, 12 - 14 May 2011, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000290641800043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fullerton JM; Tiwari Y; Schofield PR; Weickert CS, 2010, 'INCREASED FREQUENCY OF NOVEL NRG1 GENE VARIANTS IN SCHIZOPHRENIA AND THE EFFECT OF NUCLEOTIDE VARIATION ON MRNA ISOFORM TRANSCRIPTIONAL REGULATION', in SCHIZOPHRENIA RESEARCH, ELSEVIER SCIENCE BV, Florence, ITALY, pp. 334 - 335, presented at 2nd Conference of the Schizophrenia-International-Research-Society (SIRS), Florence, ITALY, 10 - 14 April 2010, http://dx.doi.org/10.1016/j.schres.2010.02.576

McAuley EZ; Blair IP; Fullerton JM; Donald JA; Mitchell PB; Schofield PR, 2006, 'Identification of a bipolar disorder susceptibility locus on chromosome 15Q', in AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, WILEY-LISS, Cagliari, ITALY, pp. 695 - 696, presented at 14th World Congress on Psychiatric Genetics, Cagliari, ITALY, 28 October - 01 November 2006, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000240877700051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

McAuley E; Blair I; Fullerton J; Donald J; Mitchell P; Schofield P, 2006, 'Identification of a bipolar disorder susceptibility locus on chromosome 15Q.', in Acta Neuropsychiatr, England, pp. 261, England, http://dx.doi.org/10.1017/S0924270800030544

Willis-Owen S; Yalcin B; Fullerton J; Meesaq A; Deacon R; Rawlins N; Copley R; Morris A; Flint J; Mott R, 2005, 'Finding quantitative trait genes that influence mouse behaviour - and investigating their role in human psychopathology', in AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, WILEY, Boston, MA, pp. 94 - 95, presented at 13th World Congress on Psychiatric Genetics, Boston, MA, 04 - 08 September 2005, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000232357300338&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fullerton J; Brady S; Cubin M; Tiwari H; Wang CX; Bomhra A; Davidson S; Miller S; Fairburn C; Goodwin G, 2004, 'Molecular approaches to identifying candidate genes in depression', in BEHAVIOR GENETICS, SPRINGER, Aix en Provence, FRANCE, pp. 639 - 639, presented at 34th Annual Meeting of the Behavior-Genetics-Association, Aix en Provence, FRANCE, 27 - 30 June 2004, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000224808200039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fullerton J; Cubin M; Bhomra A; Davidson S; Miller S; Turn M; Dolby C; Mott R; Wang C; Tiwari H, 2002, 'Linkage analysis of extremely discordant and concordant sibling pairs identifies QTL that influence variation in a human personality trait.', in AMERICAN JOURNAL OF HUMAN GENETICS, UNIV CHICAGO PRESS, BALTIMORE, MARYLAND, pp. 216 - 216, presented at 52nd Annual Meeting of the American-Society-of-Human-Genetics, BALTIMORE, MARYLAND, 15 - 19 October 2002, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000178025800265&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Fullerton JM; Paprocki P; Foote S; Mackie D; Williamson R; Forrest S, 1999, 'An association approach using eight affected individuals from Tasmania, Australia maps a locus for keratoconus.', in AMERICAN JOURNAL OF HUMAN GENETICS, UNIV CHICAGO PRESS, pp. A31 - A31, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000082879800159&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Presentations

Lenroot RK; Roberts G; Fullerton J; Overs B; Schofield P; Mitchell P, 2015, 'BIPOLAR DISORDER KIDS & SIBS STUDY: NEUROIMAGING FINDINGS IN YOUNG PEOPLE AT HIGH RISK FOR BIPOLAR DISORDER', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 49, pp. 82 - 82, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000354437500206&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Conference Abstracts

Jamshidi J; Montalto A; Chilver M; Toma C; Schofield P; Williams L; Fullerton J; Gatt J, 2019, 'Genetic factors influencing quantitative measures of subjective and psychological wellbeing using the COMPAS-W scale in a healthy Australian twin cohort', in BEHAVIOR GENETICS, SPRINGER, Karolinska Inst, Stockholm, SWEDEN, Vol. 49, pp. 511 - 511, presented at 49th Annual Meeting of the Behavior-Genetics-Association (BGA), Karolinska Inst, Stockholm, SWEDEN, 26 - 29 June 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000494050500090&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Toma C; Shaw AD; Allcock RJN; Heath A; Pierce KD; Cooper A; Mitchell PB; Schofield PR; Fullerton JM, 2019, 'The role of rare variants in bipolar disorder', in BIPOLAR DISORDERS, WILEY, Sydney, AUSTRALIA, Vol. 21, pp. 40 - 41, presented at 21st Annual ISBD Conference on Global Advances in Bipolar Disorder and Depression, Sydney, AUSTRALIA, 20 - 23 March 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461513600085&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Mitchell PB; Roberts G; Lenroot R; Overs B; Fullerton J; Leung V; Stuart A; Frankland A; Levy F; Hadzi-Pavlovic D, 2019, 'Accelerated cortical thinning and volume reduction over time in young people at high genetic risk for bipolar disorder', in BIPOLAR DISORDERS, WILEY, Sydney, AUSTRALIA, Vol. 21, pp. 66 - 66, presented at 21st Annual ISBD Conference on Global Advances in Bipolar Disorder and Depression, Sydney, AUSTRALIA, 20 - 23 March 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461513600140&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Overs BJ; Lenroot RK; Roberts G; Green MJ; Hadzi-Pavlovic D; Frankland A; Levy F; Toma C; Schofield PR; Mitchell PB, 2019, 'THE RELATIONSHIP BETWEEN FUNCTIONAL DOPAMINE D2 RECEPTOR HAPLOTYPES AND COGNITIVE OUTCOMES, AS MEDIATED BY REGIONAL BRAIN STRUCTURE: A COMPARISON OF CONTROL, AT-RISK, AND BIPOLAR DISORDER SUBJECTS', in EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE BV, Orlando, FL, Vol. 29, pp. S991 - S992, presented at 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, 13 - 17 October 2017, http://dx.doi.org/10.1016/j.euroneuro.2017.08.375

Lenroot RK; Overs B; Roberts G; Frankland A; Levy F; Toma C; Wieckert CS; Schofield P; Mitchell P; Fullerton J, 2019, 'INTERACTIVE EFFECTS OF FAMILY HISTORY, POLYGENIC RISK AND AGE ON CORTICAL THICKNESS IN YOUNG PEOPLE AT HIGH GENETIC RISK OF BIPOLAR DISORDER', in EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE BV, Orlando, FL, Vol. 29, pp. S924 - S924, presented at 25th World Congress of Psychiatric Genetics (WCPG), Orlando, FL, 13 - 17 October 2017, http://dx.doi.org/10.1016/j.euroneuro.2017.08.256

Overs B; Toma C; Havard A; Green MJ; Mitchell PB; Schofield PR; Fullerton JM, 2019, 'Identification and characterisation of bipolar disorder in Australia using administrative health data', in BIPOLAR DISORDERS, WILEY, Sydney, AUSTRALIA, Vol. 21, pp. 69 - 70, presented at 21st Annual ISBD Conference on Global Advances in Bipolar Disorder and Depression, Sydney, AUSTRALIA, 20 - 23 March 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461513600148&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Hesam-Shariati S; Overs BJ; Green MJ; Roberts G; Leung V; Stuart A; Schofield PR; Mitchell PB; Fullerton JM, 2019, 'Role of epigenetic age and stress in developing bipolar disorder at high familial risk', in BIPOLAR DISORDERS, WILEY, Sydney, AUSTRALIA, Vol. 21, pp. 106 - 106, presented at 21st Annual ISBD Conference on Global Advances in Bipolar Disorder and Depression, Sydney, AUSTRALIA, 20 - 23 March 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461513600238&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Boss P; Loo C; Fullerton J; Mitchell P, 2019, 'The Genes, Clinical Assessment and Depression (GLAD) study', in BIPOLAR DISORDERS, WILEY, Sydney, AUSTRALIA, Vol. 21, pp. 137 - 138, presented at 21st Annual ISBD Conference on Global Advances in Bipolar Disorder and Depression, Sydney, AUSTRALIA, 20 - 23 March 2019, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000461513600304&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Weickert CS; Fullerton JM; Hu S; Kyaw M; Schofield PR; Carr VJ; Laughlin C; Schall U; Scott RJ; Jablensky AV, 2016, 'SCHIZOPHRENIA AND COGNITIVE DYSFUNCTION ASSOCIATED WITH THE ESTROGEN RECEPTOR 1 GENOTYPE', in AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, SAGE PUBLICATIONS LTD, Vol. 50, pp. 77 - 77, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000375591600173&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Jahanshad N; Kochunov P; Armstrong N; Bastin M; Bearden C; Brouwer R; Cannon D; Caseras X; Costa Rica - Colombia Bipolar Consortium; Crespo-Facorro B, 2015, 'Meta-analyzing genome-wide associations with white matter microstructure - the ENIGMA-DTI group [Poster abstract 3407]', in Proceedings of the 21st Annual Meeting of the Organization for Human Brain Mapping (OHBM), 21st Annual Meeting of the Organization for Human Brain Mapping (OHBM), Honolulu, Hawaii, USA, presented at 21st Annual Meeting of the Organization for Human Brain Mapping (OHBM), Honolulu, Hawaii, USA, 14 - 18 June 2015

Schofield PR; Fullerton JM; Gatt JM; Williams LM; Mitchell PB, 2013, 'Genetic approaches to understanding the etiology of mood disorders', in JOURNAL OF MOLECULAR NEUROSCIENCE, HUMANA PRESS INC, Eilat, ISRAEL, Vol. 51, pp. S107 - S107, presented at 21st Annual Meeting of the Israel-Society-for-Neuroscience / 1st Binational Australian-Israeli Meeting on Neuroscience, Eilat, ISRAEL, 15 - 15 December 2012, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000332833800274&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Find a Person

Quick Links

	Scholarships
	Contact Us